Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 27Melanoma 4Sarcoma 3Liposarcoma 3Ovarian Neoplasms 2Neoplasms 2Breast Cancer Metastatic 2Thymus Neoplasms 1Teratoma 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma 1Locoregional Recurrence 1Liposarcoma, Myxoid 1Lipoma 1Leukemia 1Leiomyosarcoma 1Hematologic Neoplasms 1HER2-positive Advanced Breast Cancer 1HER2 Negative Breast Cancer 1Glioma 1Glioblastoma 1Fallopian Tube Neoplasms 1Estrogen Receptor and/or Progesterone Receptor Positive 1Endometrial Neoplasms 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Ifosfamide 7Etoposide 7Cisplatin 6Filgrastim 5Carboplatin 5Thiotepa 4Paclitaxel 4pegfilgrastim 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Bleomycin 3etoposide phosphate 2Neoadjuvant Therapy 2Mesna 2Granulocyte Colony-Stimulating Factor 2sargramostim 1ribociclib 1pegylated granulocyte colony-stimulating factor 1palifosfamide lysine 1palbociclib 1ixabepilone 1isophosphamide mustard 1aldesleukin 1Vincristine 1Therapeutics 1Sunitinib 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Teratoma × ribociclib × Clear all
NCT02300987 2020-10-26

A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Novartis

Phase 2 Completed
10 enrolled 12 charts

Neoplasms, Germ Cell and Embryonal, Teratoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡